Tcrcure Biopharma Ltd.
Clinical trials sponsored by Tcrcure Biopharma Ltd., explained in plain language.
-
Scientists reprogram immune cells to hunt cervical cancer
Disease control TerminatedThis early-phase trial tested a personalized cell therapy for advanced cervical cancer that had stopped responding to standard treatments. Researchers collected immune cells from patients, genetically engineered them to recognize and attack cancer cells infected with HPV16, and t…
Phase: PHASE1, PHASE2 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
First-in-Human CAR-T test for tough cancers halted early
Disease control TerminatedThis was a very early, small pilot study to test the safety of a new CAR-T cell therapy for patients with advanced solid tumors that have a specific protein called ALPP. The study involved only 5 patients who had already tried other treatments without success. The main goal was t…
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC